oseltamivir has been researched along with Allergic Bronchopulmonary Mycosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Brock, M; Fremau, A; Humblet-Baron, S; Jacobs, C; Laeveren, B; Lagrou, K; Naesens, L; Ostyn, T; Reséndiz-Sharpe, A; Seldeslachts, L; Van De Veerdonk, FL; Vande Velde, G; Vanderbeke, L; Verbeken, E; Wauters, J | 1 |
| Chuang, YC; Ku, YH; Yu, WL | 1 |
| Choi, SH; Hong, SB; Kim, MN; Kim, SH; Kim, YS; Koh, Y; Lee, SO; Lim, CM; Woo, JH | 1 |
3 other study(ies) available for oseltamivir and Allergic Bronchopulmonary Mycosis
| Article | Year |
|---|---|
Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model.
Topics: Animals; Aspergillosis; Aspergillus; Aspergillus fumigatus; Coinfection; Disease Models, Animal; Humans; Influenza, Human; Invasive Pulmonary Aspergillosis; Mice; Oseltamivir; Pulmonary Aspergillosis; X-Ray Microtomography | 2021 |
Postinfluenza A(H3N2) refractory invasive pulmonary aspergillosis.
Topics: Aged; Antiviral Agents; Bronchoalveolar Lavage Fluid; Disease Management; Disease Progression; Fatal Outcome; Hemopneumothorax; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Invasive Pulmonary Aspergillosis; Lung; Male; Nasopharynx; Oseltamivir; Radiography; Shock, Septic; Thoracentesis | 2017 |
Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Antiviral Agents; Fatal Outcome; Humans; Immunocompetence; Influenza A Virus, H1N1 Subtype; Influenza, Human; Invasive Pulmonary Aspergillosis; Male; Oseltamivir; Pyrimidines; Triazoles; Voriconazole | 2012 |